Institutional Investors Lead Shift in Bovie Medical Corp (NYSEMKT:BVX) Sentiment

June 20, 2017 - By Winifred Garcia

 Institutional Investors Lead Shift in Bovie Medical Corp (NYSEMKT:BVX) Sentiment

Sentiment for Bovie Medical Corp (NYSEMKT:BVX)

Bovie Medical Corp (NYSEMKT:BVX) institutional sentiment decreased to 1.53 in 2016 Q4. Its down -0.91, from 2.44 in 2016Q3. The ratio dived, as 23 institutional investors started new and increased stock positions, while 15 reduced and sold their stakes in Bovie Medical Corp. The institutional investors in our partner’s database now have: 9.00 million shares, up from 6.33 million shares in 2016Q3. Also, the number of institutional investors holding Bovie Medical Corp in their top 10 stock positions was flat from 1 to 1 for the same number . Sold All: 9 Reduced: 6 Increased: 12 New Position: 11.

Bovie Medical Corporation is an energy medical device company. The company has market cap of $75.63 million. The Firm is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It currently has negative earnings. It operates through three divisions: Core, OEM and J-Plasma.

About 414 shares traded. Bovie Medical Corporation (NYSEMKT:BVX) has risen 28.74% since June 20, 2016 and is uptrending. It has outperformed by 12.04% the S&P500.

Perkins Capital Management Inc holds 2.49% of its portfolio in Bovie Medical Corporation for 632,035 shares. Great Point Partners Llc owns 3.06 million shares or 2.25% of their US portfolio. Moreover, Cortina Asset Management Llc has 0.24% invested in the company for 1.58 million shares. The Connecticut-based Manatuck Hill Partners Llc has invested 0.22% in the stock. Pura Vida Investments Llc, a New York-based fund reported 123,000 shares.#img1#

More notable recent Bovie Medical Corporation (NYSEMKT:BVX) news were published by: Marketwatch.com which released: “2.41” on November 10, 2010, also Seekingalpha.com with their article: “Bovie Medical: Buy The Business, Get A Multi-Billion Dollar Product Pipeline Free” published on March 24, 2014, Seekingalpha.com published: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q4 2016 Results …” on March 10, 2017. More interesting news about Bovie Medical Corporation (NYSEMKT:BVX) were released by: Seekingalpha.com and their article: “Bovie Medical: Little Bovie May Be Running With The Big Dogs” published on July 22, 2014 as well as Businesswire.com‘s news article titled: “Bovie Medical Announce Sales Channel Partnership with CONMED for PlazXactâ„¢” with publication date: January 19, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.